Dr Katherine Margaret Beckwith, AUD | |
330 Camden Causeway, Suite D, Camden, NC 27921 | |
(252) 331-2437 | |
Not Available |
Full Name | Dr Katherine Margaret Beckwith |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 330 Camden Causeway, Camden, North Carolina |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1972106318 | NPI | - | NPPES |
1306085410 | Other | BLUE CROSS BLUE SHIELD |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
231H00000X | Audiologist | 81418 (Texas) | Primary |
231H00000X | Audiologist | 14266 (North Carolina) | Secondary |
Mailing Address | Practice Location Address |
---|---|
Dr Katherine Margaret Beckwith, AUD 4601 Spicewood Springs Rd, Bldg 2, Suite 100, Austin, TX 78759 Ph: (512) 345-4664 | Dr Katherine Margaret Beckwith, AUD 330 Camden Causeway, Suite D, Camden, NC 27921 Ph: (252) 331-2437 |
News Archive
Erchonia, the global leader in low level laser healthcare applications, today announces the launch of the Zerona® body-contouring laser in South East Asia's SAARC. Erchonia Asia will exclusively market and sell the Zerona throughout the region. This new expansion coincides with the recent U.S. FDA-approval of the Zerona Laser, a non-invasive, painless treatment that guarantees the removal of fat.
The nation's insurance commissioners are raising concerns about how much flexibility states will have to tweak their exchanges once the new insurance markets are up and running. Under the first set of exchange rules, released in July, states that want to alter their exchange plans would have to get permission from HHS.
A team of researchers from the Icahn School of Medicine at Mount Sinai, New York, have worked in collaboration to try and answer one of the most baffling questions surrounding the coronavirus disease 19 (COVID-19) pandemic: do antibodies against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) last after a primary infection?
Antibiotics used to treat a variety of common bacterial infections are becoming more difficult to access, mostly because the drugs are less profitable for manufacturers to produce and market.
› Verified 1 days ago